Previous studies indicated that MPO acts not only as a pro-inflammatory and pro-oxidant enzyme in ASCVD, but also as a pro-fibrotic mediator in the pathogenesis of AF progression11,17. The gene discussed is MPO; the disease is atherosclerosis.